MedMira Rapid HIV TestsWith over 40 million HIV infected people worldwide and nearly 5 million new cases each year, HIV is a major public health issue. MedMira’s rapid HIV tests play a fundamental role in the prevention and control strategies being implemented by healthcare providers, governments and non-profit organizations working to overcome this healthcare challenge. Fast, simple, and economical MedMira rapid HIV tests deliver substantial time and cost savings, ultimately helping more people know their HIV status. The World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) endorse the use of rapid HIV tests. MedMira rapid HIV tests are available worldwide, please select your region below to find out more.
Please note that product specifications and configurations vary depending on the market and its regulatory requirements. All products may not be available in all markets. |
Key Features & Benefits
Three minute test procedure
Instant results
Easy-to-use, no specialized training required
Built-in procedural and reagent control line
Up to 18 month shelf-life at 2 - 30 C
High sensitivity and specificity
Whole blood, serum or plasma specimens
No refrigeration required
No timers required
Results are easy to interpret
No specialized equipment required
